메인메뉴 바로가기 본문내용 바로가기

의약품 부작용신고 및 피해구제 상담 : 1644-6223 / 14-3330

첨단바이오 포커스

국민의 안전과 건강을 지키는 한국의약품안전관리원

홈 > 알림마당 > 뉴스레터 > 첨단바이오 포커스

인쇄
게시글 보기
제목 첨단바이오 포커스 제9호
등록자 hyj0117 등록일 2021-09-03 조회수 2206



























Reference

1. 식품의약품안전처 홈페이지Available from: https://www.mfds.go.kr/brd/m_99/view.do?seq=45644&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=3

2. 식품의약품안전처 홈페이지Available from: https://www.mfds.go.kr/brd/m_203/view.do?seq=3155

3. 식품의약품안전처 홈페이지Available from: https://www.mfds.go.kr/brd/m_99/view.do?seq=45602&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=3

4. 식품의약품안전처 홈페이지Available from: https://www.mfds.go.kr/brd/m_1059/view.do?seq=14859&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=1

5. 보건복지부 홈페이지Available from: http://www.mohw.go.kr/react/al/sal0301vw.jsp?PAR_MENU_ID=04&MENU_ID=0403&page=3&CONT_SEQ=366707

6. “Cumulative CBER Regenerative Medicine Advanced Therapy (RMAT) Designation Requests Received by Fiscal Year” US FDA Accessed July 6, 2021 Available from: https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/cumulative-cber-regenerative-medicine-advanced-therapy-rmat-designation-requests-received-fiscal

7. “Questions and Answers Regarding the End of the Compliance and Enforcement Policy for Certain Human Cells, Tissues, or Cellular or Tissue-based Products (HCT/Ps)” US FDA

Accessed July 9, 2021Available from: https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/questions-and-answers-regarding-end-compliance-and-enforcement-policy-certain-human-cells-tissues-or

8. “CBER targets four stem cell firms with untitled letters” Regulatory Focus

Accessed July 20, 2021 Available from: https://www.raps.org/news-and-articles/news-articles/2021/7/cber-pummels-four-firms-for-marketing-unapproved-s

9. “Regulatory Education for Industry (REdI) Annual Conference 2021” US FDA Accessed July 23, 2021

Available from: https://www.fda.gov/drugs/regulatory-education-industry-redi-annual-conference-2021-07192021-07232021

10. “Cellular, Tissue, and Gene Therapies Advisory Committee September 2-3, 2021 Meeting Announcement” US FDA Accessed July 27, 2021

Available from: https://www.fda.gov/advisory-committees/advisory-committee-calendar/cellular-tissue-and-gene-therapies-advisory-committee-september-2-3-2021-meeting-announcement

11. “Committee for Advanced Therapies (CAT): work-plan-Jul” EMA. Accessed Jul. 15, 2021 Available from: https://www.ema.europa.eu/en/events/committee-advanced-therapies-cat-14-16-july-2021

12. EMA 홈페이지 Available from: https://www.ema.europa.eu/en/medicines/human/referrals/zynteglo

13. “Orphan designations-eu3181999” EMA. Accessed Jul. 1. 2021

Available from: https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3181999

https://www.ema.europa.eu/en/medicines/human/referrals/zynteglo

14. “Orphan designations-eu3171950” EMA. Accessed Jul. 12. 2021

Available from: https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3171950

15. “Orphan designations-eu3202351” EMA. Accessed Jul. 12. 2021

Available from: https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3202351

16. “Orphan designations-eu3151577” EMA. Accessed Jul. 12. 2021

Available from: https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3151577

17. “Orphan designations-eu3121002” EMA. Accessed Jul. 16. 2021

Available from: https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3121002

18. “Orphan designations-eu3192138” EMA. Accessed Jul. 21. 2021

Available from: https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3192138

19. “Orphan designations-eu3121003” EMA. Accessed Jul. 27. 2021

Available from: https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3121003

20. “Yescarta” EMA. Accessed Jul. 8, 2021

Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/yescarta

21. “Sperox” EMA. Accessed Jul. 14, 2021

Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/spherox

22. PMDA 홈페이지Available from: https://www.pmda.go.jp/english/symposia/0211.html

23. “JMuscles retain positional memory from fetal life” Eurekalert. Accessed July. 6, 2021

Available from: https://www.eurekalert.org/news-releases/575847

24. 유럽의약품청 의약품허가제도, 식품의약품안전평가원 APEC규제조화센터,2020.12

25. “advanced-therapy-medicinal-products-overview” EU EMA 홈페이지

Available from: https://www.ema.europa.eu/en/human-regulatory/overview/advanced-therapy-medicinal-products-overview

26. “committee-advanced-therapies-cat-overview” EU EMA 홈페이지

Available from: https://www.ema.europa.eu/en/committees/committee-advanced-therapies-cat

27. “European Medicines Agency pre-authorisation procedural advice for

users of the centralised procedure. EMA/821278/2015”, EU EMA, Accessed 2019

28. “Scientific Recommendation on classification of Advanced Therapy Medicinal

Products Request Form and Briefing Information Article 17 - Regulation (EC)

No 1394/2007”, EU EMA, Accessed 2019

29. “Legal framework: Advanced Therapies” EU EMA 홈페이지 Available from:

https://www.ema.europa.eu/en/human-regulatory/overview/advanced-therapies/legal-framework-advanced-therapies

30. “regulatory procedural guideline CAT rules procedure”, EU EMA, Accessed

March 19, 2020 Available from: https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/cat-rules-procedure_en.pdf

31. “CAT members: The European Medicines Agency publishes details of the

members and alternates of its Committee for Advanced Therapies” EU EMA 홈

페이지 Available from: https://www.ema.europa.eu/en/committees/cat/members

32. “CAT agenda june 2021 meeting”, EU EMA, Accessed June 16, 2021

Available from: https://www.ema.europa.eu/en/committees/cat/cat-agendas-minutes-reports

33. 첨단바이오의약품 원료세포 품질 안전기준 마련 및 교육, 한국의약품안전관리원, 2020.11

34. “committee advanced therapies european society gene cell therapy satellite

workshop advanced therapy” ,EU EMA, Accessed Oct 27, 2011

Available from: https://www.ema.europa.eu/en/events/committee-advanced-therapies-european-society-gene-cell-therapy-satellite-workshop-advanced-therapy

35. “cat translational centre regenerative medicine leipzig collaborative

workshop advanced therapy” ,EU EMA, Accessed Oct 23, 2013

Available from: https://www.ema.europa.eu/en/events/cat-translational-centre-regenerative-medicine-leipzig-collaborative-workshop-advanced-therapy

36. “committee advanced therapies cat german society transfusion medicine

immunohaematology dgti workshop”, EU EMA, Accessed Sep 11, 2014

Available from: https://www.ema.europa.eu/en/events/committee-advanced-therapies-cat-german-society-transfusion-medicine-immunohaematology-dgti-workshop

37. “committee advanced therapies cat international society cellular therapy

isct workshop challenges”, EU EMA, Accessed Sep 25, 2015

Available from: https://www.ema.europa.eu/en/events/committee-advanced-therapies-cat-international-society-cellular-therapy-isct-workshop-challenges

38. “committee advanced therapies cat workshop scientific regulatory challenges genetically modified cell”, EU EMA, Accessed Nor 11, 2016

Available from: https://www.ema.europa.eu/en/events/committee-advanced-therapies-cat-workshop-scientific-regulatory-challenges-genetically-modified-cell

첨부파일
첨단바이오포커스 제9호 _21년 9월.pdf [27040205 byte]